NASDAQ:DH Definitive Healthcare (DH) Stock Price, News & Analysis → An utter travesty (From The Freeport Society) (Ad) Free DH Stock Alerts $5.74 -0.26 (-4.33%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$5.67▼$6.0850-Day Range$5.17▼$7.9252-Week Range$4.38▼$12.45Volume675,618 shsAverage Volume1.01 million shsMarket Capitalization$676.92 millionP/E RatioN/ADividend YieldN/APrice Target$9.94 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Definitive Healthcare alerts: Email Address Definitive Healthcare MarketRank™ Stock AnalysisAnalyst RatingHold2.18 Rating ScoreUpside/Downside73.2% Upside$9.94 Price TargetShort InterestHealthy8.80% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.98Based on 4 Articles This WeekInsider TradingN/AProj. Earnings Growth50.00%From $0.10 to $0.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.82 out of 5 starsMedical Sector209th out of 917 stocksPrepackaged Software Industry62nd out of 198 stocks 4.1 Analyst's Opinion Consensus RatingDefinitive Healthcare has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 2 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageDefinitive Healthcare has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Definitive Healthcare's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted8.80% of the float of Definitive Healthcare has been sold short.Short Interest Ratio / Days to CoverDefinitive Healthcare has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in Definitive Healthcare has recently decreased by 11.18%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldDefinitive Healthcare does not currently pay a dividend.Dividend GrowthDefinitive Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DH. Previous Next 2.2 News and Social Media Coverage News SentimentDefinitive Healthcare has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for DH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Definitive Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders14.84% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Definitive Healthcare's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Definitive Healthcare are expected to grow by 50.00% in the coming year, from $0.10 to $0.15 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Definitive Healthcare is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Definitive Healthcare is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioDefinitive Healthcare has a PEG Ratio of 4.34. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioDefinitive Healthcare has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Definitive Healthcare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Freeport SocietyAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. About Definitive Healthcare Stock (NASDAQ:DH)Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Read More DH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DH Stock News HeadlinesJune 12 at 1:36 AM | americanbankingnews.comDefinitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of "Hold" from BrokeragesJune 11 at 9:15 AM | globenewswire.comDefinitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year AwardJune 3, 2024 | globenewswire.comDefinitive Healthcare Publishes 2023 Sustainability ReportMay 29, 2024 | globenewswire.comDefinitive Healthcare to Present at the Stifel 2024 Cross Sector Insight ConferenceMay 28, 2024 | bizjournals.comDefinitive Healthcare names new CEOMay 28, 2024 | finance.yahoo.comDefinitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company’s GrowthMay 28, 2024 | globenewswire.comDefinitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's GrowthMay 14, 2024 | globenewswire.comDefinitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications ConferenceMay 11, 2024 | seekingalpha.comDefinitive Healthcare Corp. 2024 Q1 - Results - Earnings Call PresentationMay 10, 2024 | markets.businessinsider.comHold Rating Justified by Mixed Financial Performance and Uncertain Outlook for Definitive Healthcare CorpMay 9, 2024 | finance.yahoo.comDefinitive Healthcare First Quarter 2024 Earnings: EPS Misses ExpectationsMay 9, 2024 | msn.comMorgan Stanley Downgrades Definitive Healthcare (DH)May 8, 2024 | markets.businessinsider.comExpert Outlook: Definitive Healthcare Through The Eyes Of 4 AnalystsMay 8, 2024 | msn.comDefinitive Healthcare's slowing revenue growth prompts downgrade at Morgan StanleyMay 8, 2024 | markets.businessinsider.comBuy Definitive Healthcare Stock On Weakness, Analyst Says As Revised Outlook Appears AchievableMay 8, 2024 | finance.yahoo.comQ1 2024 Definitive Healthcare Corp Earnings CallMay 8, 2024 | finance.yahoo.comDefinitive Healthcare Corp (DH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 7, 2024 | msn.comDH Stock Earnings: Definitive Healthcare Meets EPS, Misses Revenue for Q1 2024May 7, 2024 | finance.yahoo.comDefinitive Healthcare Reports Financial Results for First Quarter Fiscal Year 2024April 27, 2024 | nasdaq.comCommit To Buy Definitive Healthcare Corp At $5, Earn 12.2% Annualized Using OptionsApril 23, 2024 | globenewswire.comDefinitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and WebcastApril 16, 2024 | finance.yahoo.comDefinitive Healthcare introduces Carevoyance sales enablement solution for medtech industryMarch 22, 2024 | markets.businessinsider.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 22, 2024 | globenewswire.comVML and Definitive Healthcare announce partnership to transform key opinion leader managementMarch 21, 2024 | markets.businessinsider.comNeedham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)See More Headlines Receive DH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/07/2024Today6/14/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Prepackaged software Sub-IndustryN/A Current SymbolNASDAQ:DH CUSIPN/A CIK1861795 Webwww.definitivehc.com Phone508-720-4224FaxN/AEmployees950Year FoundedN/APrice Target and Rating Average Stock Price Target$9.94 High Stock Price Target$15.00 Low Stock Price Target$7.00 Potential Upside/Downside+73.2%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.75) Trailing P/E RatioN/A Forward P/E Ratio57.40 P/E Growth4.23Net Income$-202,390,000.00 Net Margins-78.16% Pretax Margin-119.28% Return on Equity0.51% Return on Assets0.34% Debt Debt-to-Equity Ratio0.20 Current Ratio2.30 Quick Ratio2.30 Sales & Book Value Annual Sales$251.41 million Price / Sales2.69 Cash Flow$3.04 per share Price / Cash Flow1.89 Book Value$10.31 per share Price / Book0.56Miscellaneous Outstanding Shares117,930,000Free Float100,433,000Market Cap$676.92 million OptionableNot Optionable Beta1.29 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jason Ronald Krantz (Age 50)Founder, Executive Chairman & Interim CEO Comp: $130.38kMr. Jonathan Maack (Age 45)President Comp: $687.21kMr. Richard Douglas Booth (Age 55)Chief Financial Officer Comp: $579.47kMs. Kate Marie Shamsuddin Jensen (Age 37)Chief Strategy Officer Comp: $431.86kMs. Carrie Lazorchak (Age 54)Chief Revenue Officer Comp: $110.49kMr. Matthew RudermanChief Legal Officer & SecretaryMr. Craig HazenfieldChief People OfficerMr. Scott OberlinkChief Technology OfficerMr. Ram SharmaExecutive Vice President of Life SciencesMr. William Moschella (Age 48)Chief Product & Technology Officer More ExecutivesKey CompetitorsExpensifyNASDAQ:EXFYLivePersonNASDAQ:LPSNAlkami TechnologyNASDAQ:ALKTN-ableNYSE:NABLIntappNASDAQ:INTAView All CompetitorsInsiders & InstitutionsBoston PartnersBought 68,176 shares on 5/28/2024Ownership: 0.058%Comerica BankBought 37,044 shares on 5/17/2024Ownership: 0.370%Clearbridge Investments LLCSold 1,991,131 shares on 5/13/2024Ownership: 0.226%Vanguard Group Inc.Bought 67,068 shares on 5/10/2024Ownership: 3.850%Swiss National BankBought 2,900 shares on 5/7/2024Ownership: 0.088%View All Insider TransactionsView All Institutional Transactions DH Stock Analysis - Frequently Asked Questions Should I buy or sell Definitive Healthcare stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares. View DH analyst ratings or view top-rated stocks. What is Definitive Healthcare's stock price target for 2024? 11 brokers have issued 1 year price objectives for Definitive Healthcare's shares. Their DH share price targets range from $7.00 to $15.00. On average, they predict the company's stock price to reach $9.94 in the next twelve months. This suggests a possible upside of 73.2% from the stock's current price. View analysts price targets for DH or view top-rated stocks among Wall Street analysts. How have DH shares performed in 2024? Definitive Healthcare's stock was trading at $9.94 at the beginning of the year. Since then, DH shares have decreased by 42.3% and is now trading at $5.74. View the best growth stocks for 2024 here. Are investors shorting Definitive Healthcare? Definitive Healthcare saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 4,450,000 shares, a drop of 11.2% from the May 15th total of 5,010,000 shares. Based on an average daily trading volume, of 834,600 shares, the short-interest ratio is presently 5.3 days. Approximately 8.8% of the company's stock are short sold. View Definitive Healthcare's Short Interest. When is Definitive Healthcare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024. View our DH earnings forecast. How were Definitive Healthcare's earnings last quarter? Definitive Healthcare Corp. (NASDAQ:DH) issued its quarterly earnings results on Tuesday, May, 7th. The company reported ($0.02) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.04. Definitive Healthcare had a positive trailing twelve-month return on equity of 0.51% and a negative net margin of 78.16%. What ETFs hold Definitive Healthcare's stock? ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) and Fidelity Digital Health ETF (FDHT).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). What guidance has Definitive Healthcare issued on next quarter's earnings? Definitive Healthcare updated its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of 0.080-0.090 for the period, compared to the consensus estimate of 0.090. The company issued revenue guidance of $62.0 million-$63.5 million, compared to the consensus revenue estimate of $65.2 million. When did Definitive Healthcare IPO? Definitive Healthcare (DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share. Who are Definitive Healthcare's major shareholders? Definitive Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (4.75%), Vanguard Group Inc. (3.85%), Riverbridge Partners LLC (1.49%), Raymond James & Associates (0.72%), Comerica Bank (0.37%) and Clearbridge Investments LLC (0.23%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc. View institutional ownership trends. How do I buy shares of Definitive Healthcare? Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DH) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityIt's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more poten...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredMy 3 Top CryptocurrenciesMore than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Definitive Healthcare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Definitive Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
